KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Common Equity (2016 - 2026)

Pfizer has reported Common Equity over the past 18 years, most recently at $90.4 billion for Q1 2026.

  • Quarterly Common Equity changed 0.26% to $90.4 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $90.4 billion through Mar 2026, changed 0.26% year-over-year, with the annual reading at $86.8 billion for FY2025, 1.95% down from the prior year.
  • Common Equity was $90.4 billion for Q1 2026 at Pfizer, up from $86.8 billion in the prior quarter.
  • Over five years, Common Equity peaked at $101.2 billion in Q2 2023 and troughed at $82.7 billion in Q2 2022.
  • The 5-year median for Common Equity is $90.6 billion (2025), against an average of $91.6 billion.
  • Year-over-year, Common Equity soared 160.16% in 2022 and then decreased 11.4% in 2024.
  • A 5-year view of Common Equity shows it stood at $95.9 billion in 2022, then fell by 6.91% to $89.3 billion in 2023, then decreased by 0.89% to $88.5 billion in 2024, then fell by 1.95% to $86.8 billion in 2025, then rose by 4.18% to $90.4 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Common Equity are $90.4 billion (Q1 2026), $86.8 billion (Q4 2025), and $93.1 billion (Q3 2025).